Read More Pharma Industry News Scribe Therapeutics IPO raises $128.7m as CRISPR biotech prepares to trade as SCTX Scribe Therapeutics expanded the offering by 20% and priced shares at the top of its range, strengthening its balance sheet before crucial STX-1150 human data expected in 2027. byPallavi MadhirajuJuly 24, 2026